Last reviewed · How we verify
NCT03644927
Exercise Maintenance in Chronic Pain and PTSD
NA trial testing Progressive exercise training in Chronic Low Back Pain in 11 participants. Terminated before completion.
6 January 2022
Quick facts
| Lead sponsor | Boston University |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 22 January 2019 |
| Primary completion | 6 January 2022 |
| Estimated completion | 6 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Progressive exercise training
- Waitlist Control
Conditions studied
- Chronic Low Back Pain — all drugs for Chronic Low Back Pain →
- Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
Sponsor
Boston University
Who can join
Adults 18 to 65, any sex, with Chronic Low Back Pain or Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Adverse events — posted to ClinicalTrials.gov
Time frame: Adverse events were collected for the 6 weeks that one participant received the study intervention prior to study termination. In addition prior to randomization two participants had an adverse event during the rigorous and conservative screening process and they were not allowed to proceed to the intervention. One participant felt nauseous and had a headache and the other had abnormal EKG findings and a positive history for cardiac issues.. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.
Other adverse events (3 terms — click to expand)
| Reaction | System | Progressive Exercise Program |
|---|---|---|
| Nausea | Gastrointestinal disorders | — |
| Headache | General disorders | — |
| Cardiac abnormalities | Cardiac disorders | — |
Data from ClinicalTrials.gov NCT03644927 adverse events section.
Sponsor's own description
The primary purpose of the R21 is using an experimental medicine research approach to study whether a chronic, progressive-based exercise program will help Veterans suffering from chronic low back pain (cLBP) and PTSD achieve exercise maintenance, and shared symptom reduction, through neuropeptide Y mediated improvements in putative factors (self-regulation and reward sensitivity) known to improve exercise related self-efficacy and motivation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Moderated mediation for exercise maintenance in pain and posttraumatic stress disorder: A randomized trial.
Scioli ER, Smith BN, Whitworth JW, Spiro A, et al · · 2020 · cited 3× · PMID 32833484 · DOI 10.1037/hea0000876
Verify or expand the search:
- PubMed search for NCT03644927
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Low Back Pain
Currently open trials in the same condition.
- NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
- NCT06419439 — Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression · Phase 2 · recruiting
- NCT07241559 — Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain · NA · recruiting
- NCT07132762 — The Effect of ESWT Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Bac · NA · recruiting
Other Boston University trials
Trials by the same sponsor.
- NCT07199634 — Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0) · NA · not yet recruiting
- NCT05838378 — Cigarillo Warnings Image Sorting Study · NA · completed
- NCT06088277 — Texting to Reduce Human Immunodeficiency Virus (HIV) Risk · NA · recruiting
- NCT06455111 — Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study · NA · completed
- NCT06003439 — Vaping Prevention and Vaping in Youth (Vapechat) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03644927 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Boston University
- Last refreshed: 25 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03644927.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing